Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Kintara Therapeutics: Q2 Earnings Insights

Kintara Therapeutics (NASDAQ:KTRA) reported its Q2 earnings results on Friday, February 11, 2022 at 08:15 AM. Here's what investors need to know about the announcement.
byBenzinga Insights
February 11, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Kintara Therapeutics (NASDAQ:KTRA) reported its Q2 earnings results on Friday, February 11, 2022 at 08:15 AM.

Here’s what investors need to know about the announcement.

Earnings

Kintara Therapeutics beat estimated earnings by 25.0%, reporting an EPS of $-0.12 versus an estimate of $-0.16.

Revenue was down $0.00 from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.11, which was followed by a 3.73% drop in the share price the next day.

Listen to the earnings announcement yourself by clicking here.

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Earnings Preview For Mind Medicine

By Benzinga Insights
Today, 2:59 AM
Mind Medicine (NASDAQ:MNMD) is set to give its latest quarterly earnings report on Monday, 2022-05-16. Here's what investors need to know before the announcement. Analysts estimate that Mind Medicine will report an earnings per share (EPS) of $-0.05.

MNMD